Semaglutide and tirzepatide are both highly effective weekly injectable medications for weight loss and blood sugar management, but tirzepatide typically yields greater weight reduction
Others focus on payout speed and helpfulness of support staff
Newer triple agonists Retatrutide , the investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, showed higher overall GI event rates in Phase 2 trials at its highest doses
P = .008) and 0.4% (95% CI 0.67, 0.13
Asked a few weeks ago by this newspaper about the medications approximate launch date in Spain, Francisco Pajuelo, Novo Nordisks medical director in Spain, declined to specify a date and commented that the drug shortages will continue throughout 2023. Sign up for our weekly newsletter to get more English-language news coverage from EL PAS USA Edition
How to Administer Tirzepatide Tirzepatide is administered as a once-weekly subcutaneous injection